Pillstats
Rx only · Injection, Solution · Subcutaneous

Pegfilgrastim-Cbqv

Brands: Udenyca · Pegfilgrastim

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)338036
US makers2 labelers
Packages6
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.6K5.1K7.7K10K2025 Q12025 Q22025 Q32025 Q42026 Q1
5.0K
Rx · 2026 Q1
3.2K
Units dispensed
-10%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Accord BioPharma Inc.unknown3SUPPLYING
Coherus Oncology, Inc.unknown3SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 16, 2026
    RECALLRecall (Class I): UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactured by Accord BioPh…

    Temperature Abuse. 116 cartons with specific serial numbers of Lot 2199821, were stored incorrectly in a controlled room temperature environment instead of the required refrigerated environment. — Recalling firm: McKesson — Nationwide in the USA